The number of healthcare professionals who volunteered to display leaflets, posters and stickers in their local communities rose to more than 2,050, up by almost 30% on last year.
The Continence Foundation’s Awareness Week, which took place on 17–23 September this year, is an annual campaign to publicise the professional help available for men and women with bladder or bowel control problems. It also aims to counter the stigma associated with the condition and the myths that prevent people seeking help.
Media coverage included a feature in Top Santé magazine, an article in Woman’s Weekly and coverage on the BBC Interactive community pages, among others. The foundation also took part in a series of radio programmes on the first day of the campaign. Twenty-nine local radio stations from across the UK featured items about continence problems, reaching an estimated total audience of 1.66 million listeners.
Many of the foundation’s supporters organised local publicity activities such as information stands in shopping centres or town halls. By utilising the promotional materials provided in their free campaign pack, a number of them also attracted local media coverage.
For further information about Continence Awareness Week, email firstname.lastname@example.org (including a postal address).
Evidence base remains poor for botulinum toxin injections, Cochrane review researchers conclude
The efficacy of using intravesical botulinum toxin to treat overactive bladder syndrome is supported by little more than anecdotal evidence and case reports, according a Cochrane review. In addition, the optimal dose of botulinum toxin for efficacy and safety has not been identified.
Eight studies were included in the review. Overall, botulinum toxin performed better than placebos in outcomes such
as incontinence episodes, bladder capacity, maximum detrusor pressure and quality of life.
Low doses of botulinum toxin (100U to150U) appeared to have beneficial effects but higher doses (300U) may have been more effective.
The treatment appeared to involve few side-effects or complications but the authors did not identify any long-term follow-up studies.